z-logo
open-access-imgOpen Access
Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting?
Author(s) -
Alexander J. Bridges,
Ranjit K. Mehta,
Sushmita Shukla,
Matthew J. Schipper,
Theodore S. Lawrence,
Mukesh K. Nyati
Publication year - 2021
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.27931
Subject(s) - medicine , clinical trial , intensive care medicine , drug development , harm , drug , risk analysis (engineering) , rule of thumb , bench to bedside , clinical study design , pharmacology , medical physics , computer science , psychology , social psychology , algorithm

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom